GEODE CAPITAL MANAGEMENT, LLC
Position in RARE — Ultragenyx Pharmaceutical Inc.
CIK 1214717
BOSTON, MA
Position in RARE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$86,107,066
+$47,362,326 QoQ
Shares Held
2,578,828
+39.4% QoQ
Ownership
2.62%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 311 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RARE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $22,039,482,949 across 521 Biotechnology names. RARE ranks #54 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in RARE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $86,107,066 | 2,578,828 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $38,744,740 | 1,849,391 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $42,278,784 | 1,838,208 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $47,541,650 | 1,580,507 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $62,282,170 | 1,712,931 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $59,621,104 | 1,646,537 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $65,746,574 | 1,562,790 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $87,273,548 | 1,571,081 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $61,874,322 | 1,505,458 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $62,556,475 | 1,339,826 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $61,382,804 | 1,283,622 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $38,619,181 | 1,083,287 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $48,926,077 | 1,060,613 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $40,687,064 | 1,014,640 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $45,543,779 | 983,030 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $38,299,156 | 924,877 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $54,213,817 | 908,713 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $65,568,598 | 902,900 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $73,743,230 | 876,956 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $76,306,782 | 846,067 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $77,729,224 | 815,199 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $122,574,047 | 1,076,533 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $135,248,739 | 977,019 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $70,584,525 | 858,797 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $67,097,272 | 857,802 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $36,298,199 | 816,975 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||